Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Gastroenterology

• Publication date

  1994-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0016-5085(94)90227-5PMID 7926456
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathogenesis of ulcerative colitis.

  1993cited by this paper
• Osteoporosis and normal weight bulimia nervosa--which patients are at risk?

  1993cited by this paper
• Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease.

  1993cited by this paper
• Cytokines and bone.

  1992cited by this paper
• Longitudinal study of cortical bone loss in patients with inflammatory bowel disease.

  1992cited by this paper
• Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease.

  1992cited by this paper
• Low bone mineral density in patients with inflammatory bowel disease

  1992cited by this paper
• Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon gamma inducers.

  1991cited by this paper
• Corticosteroids and osteoporosis.

  1990cited by this paper
• Clinical features, morbidity and mortality of Scottish children with inflammatory bowel disease.

  1990cited by this paper
• Local and systemic factors in the pathogenesis of osteoporosis.

  1988cited by this paper
• Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease.

  1988cited by this paper
• Local and systemic factors in the pathogenesis of osteoporosis.

  1988cited by this paper
• Osteoporosis in patients with inflammatory bowel disease.

  1987cited by this paper
• Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia.

  1987cited by this paper
• Measurement of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in clinical settings.

  1984cited by this paper
• A short questionnaire for the measurement of habitual physical activity in epidemiological studies.

  1982cited by this paper
• Vitamin D deficiency and bone disease in patients with Crohn's disease.

  1982cited by this paper
• Calcium balance and bone mineral content following small-intestinal resection.

  1981cited by this paper
• A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis.

  1978cited by this paper
• Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

  1976cited by this paper
• Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass.

  1974cited by this paper
• PRACTICAL CLINICAL BIOCHEMISTRY

  1959cited by this paper

• Incidence of Osteoporosis and Osteopenia in Newly Diagnosed Inflammatory Bowel Disease: A Population-Based Cohort Study.

  2025cites this paper
• Metabolic musculoskeletal disorders in patients with inflammatory bowel disease

  2025cites this paper
• Association between inflammatory bowel disease and osteoporosis in European and East Asian populations: exploring causality, mediation by nutritional status, and shared genetic architecture

  2024cites this paper
• Bone health in inflammatory bowel disease

  2023cites this paper
• Sex Difference in Amebiasis.

  2023cites this paper
• A Systematic Review and Meta-Analysis on Metabolic Bone Disease in Patients with Primary Sclerosing Cholangitis

  2022cites this paper
• Intestinal Inflammation Promotes MDL-1+ Osteoclast Precursor Expansion to Trigger Osteoclastogenesis and Bone Loss

  2022cites this paper
• Effects of Digestive Diseases on Bone Metabolism

  2021cites this paper
• Pathogenesis of Musculoskeletal Deficits in Children and Adults with Inflammatory Bowel Disease

  2021cites this paper
• Prevalence of low bone mineral density in inflammatory bowel disease and factors associated with it

  2020cites this paper
• Inflammatory Bowel Disease: A Nationwide Study of Hip Fracture and Mortality Risk after Hip Fracture.

  2020cites this paper
• Mendelian randomization study of inflammatory bowel disease and bone mineral density

  2020cites this paper
• Serum N-terminal telopeptide of type I collagen as a biomarker for predicting bone density loss in patients with Crohn disease

  2020cites this paper
• Nutritional approach as therapeutic manipulation in inflammatory bowel disease

  2019cites this paper
• Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist☆

  2019cites this paper
• Prevalence, Risk Factors and Course of Osteoporosis in Patients with Crohn’s Disease at a Tertiary Referral Center

  2019cites this paper
• Bone Metabolism in Inflammatory Bowel Disease and Celiac Disease

  2019cites this paper
• Metabolic bone disease in patients diagnosed with inflammatory bowel disease from Spain

  2019cites this paper
• The Role of Vitamin D in Inflammatory Bowel Disease: Mechanism to Management

  2019cites this paper
• Metabolic Bone Disease in Gastrointestinal Disorders

  2019cites this paper
• Bone Mineral Density and Bone Remodeling in Tunisian Patients with Inflammatory Bowel Disease

  2019cites this paper
• Bone alterations in inflammatory bowel diseases

  2019cites this paper
• Bone mineralization disorder in children with inflammatory bowel disease

  2018cites this paper
• IL-6, IL-1β, and TNF-α only in combination influence the osteoporotic phenotype in Crohn's patients via bone formation and bone resorption.

  2018cites this paper
• Complications, symptoms, quality of life and pregnancy in cholestatic liver disease

  2018cites this paper
• Ülseratif kolit hastalığı kemik mineral yoğunluğunu etkiler mi

  2018cites this paper
• Crohn’s disease patient serum changes protein expression in a human mesenchymal stem cell model in a linear relationship to patients’ disease stage and to bone mineral density

  2018cites this paper
• Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission

  2017cites this paper
• Explorer Low body mass not vitamin D receptor polymorphisms predict osteoporosis in patients with inflammatory bowel disease

  2017cites this paper
• Efficacy and safety of medical therapy for low bone mineral density in patients with Crohn disease

  2017cites this paper
• Exercise and Inflammatory Bowel Disease: Insights into Etiopathogenesis and Modification of Clinical Course.

  2017cites this paper
• Inflammatory diseases and bone fragility

  2017cites this paper
• Metabolic Bone Disease in Patients with Malabsorption

  2016cites this paper
• PROGRESOS EN GASTROENTEROLOGÍA

  2016cites this paper
• Os et intestin. Prise en charge des ostéopathies associées aux pathologies intestinales

  2016cites this paper
• High-resolution Quantitative Computed Tomography Demonstrates Structural Defects in Cortical and Trabecular Bone in IBD Patients.

  2016cites this paper
• Is insulin-like growth factor 1 (IGF-1) system an attractive target inflammatory bowel diseases? Benefits and limitation of potential therapy

  2016cites this paper
• Clinical Course of Bone Metabolism Disorders in Patients with Inflammatory Bowel Disease: A 5-Year Prospective Study

  2016cites this paper
• 186 Non-Specific Inflammatory Bowel Diseases and Osteoporosis

  2016cites this paper
• Osteoporosis in Gastrointestinal Diseases.

  2016cites this paper
• Sex-Specific Issues in Inflammatory Bowel Disease.

  2015cites this paper
• Adalimumab Therapy Has a Beneficial Effect on Bone Metabolism in Patients with Crohn’s Disease

  2015cites this paper
• Bone Mineral Density in Patients with Newly Diagnosed Inflammatory Bowel Disease: Frequency and Risk Factors in Tunisian Population. Results of a Prospective Study

  2015cites this paper
• Osteoprotegerin, s-RANKL, and selected interleukins in the pathology of bone metabolism in patients with Crohn's disease

  2015cites this paper
• An Increased Serum N-Terminal Telopeptide of Type I Collagen, a Biochemical Marker of Increased Bone Resorption, Is Associated with Infliximab Therapy in Patients with Crohn’s Disease

  2015cites this paper
• Risk factors for decreased bone mineral density in inflammatory bowel disease: A cross-sectional study.

  2015cites this paper
• La maladie de Crohn, épidémiologie, traitements actuels et en développement dont l'anticorps anti-intégrine alpha4beta7

  2014cites this paper
• Vitamin D Deficiency and Corticosteroid Use Are Risk Factors for Low Bone Mineral Density in Inflammatory Bowel Disease Patients

  2014cites this paper
• Dietary calcium intake in patients with inflammatory bowel disease.

  2014cites this paper
• Postprandial response of bone turnover markers in patients with Crohn's disease.

  2014cites this paper
• Risk factors and management of osteoporosis in inflammatory bowel disease

  2014cites this paper
• Therapie der extraintestinalen CED-Manifestationen

  2014cites this paper
• Manipulating bone disease in inflammatory bowel disease patients

  2013cites this paper
• A Primer on IBD: Phenotypes, Diagnosis, Treatment, and Clinical Challenges

  2013cites this paper
• The Early Onset of Disease May Be a Risk Factor for Decreased Bone Mineral Density in Patients with Inflammatory Bowel Disease

  2013cites this paper
• The prevalence and risk factors for osteoporosis in patients with inflammatory bowel disease.

  2013cites this paper
• The prevalence and risk factors for osteoporosis in patients with infl ammatory bowel disease

  2013cites this paper
• Osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in children with inflammatory bowel disease Stężenie osteoprotegeryny i liganda receptora aktywującego czynnik jądrowy κB w przebiegu nieswoistych zapaleń jelit u dzieci

  2013cites this paper
• Inflammatory bowel disease has a small effect on bone mineral density and risk for osteoporosis.

  2013cites this paper
• Risks of Inflammatory Bowel Disease Treatment with Glucocorticosteroids and Aminosalicylates

  2013cites this paper
• Risk Factors for Osteoporosis in Crohn's Disease: Infliximab, Corticosteroids, Body Mass Index, and Age of Onset

  2013influential citation
• Inflammatory bowel disease and the risk of osteoporosis and fracture.

  2013cites this paper
• Therapie der extraintestinalen CED-Manifestationen

  2013cites this paper
• Inflammatory bowel disease and the risk of fracture after controlling for FRAX

  2013cites this paper
• Bone Density and Bone Metabolism in Patients with Inflammatory Bowel Disease

  2012cites this paper
• Exposing the position of dairy products on health in the context of obesity and gut health: implications for research and practice

  2012cites this paper
• Abnormal bone metabolism in Crohn's disease.

  2012cites this paper
• Manifestations osseuses et articulaires au cours des maladies inflammatoires chroniques intestinales

  2012cites this paper
• Frequency of Low Bone Mineral Density in Saudi Patients with Inflammatory Bowel Disease

  2012cites this paper
• Evaluation of lactose and milk intolerance, and bone mineral density in Indian patients with inflammatory bowel disease.

  2012cites this paper
• Low bone mineral density in Greek patients with inflammatory bowel disease: prevalence and risk factors

  2011cites this paper
• Assessment and management of low bone density in inflammatory bowel disease and performance of professional society guidelines1

  2011cites this paper
• Bone Mineral Density, Vitamin D, and Disease Activity in Children Newly Diagnosed with Inflammatory Bowel Disease

  2011cites this paper
• Effects of dairy products on crohn's disease symptoms are influenced by fat content and disease location but not lactose content or disease activity status in a New Zealand population.

  2011cites this paper
• Bone loss in inflammatory Bowel disease: our multicentric study

  2011cites this paper
• [Bone metabolism changes in 100 patients with inflammatory bowel disease].

  2011cites this paper
• 44 – Crohn’s Disease

  2011cites this paper
• Inflammatory bowel disease in the geriatric population.

  2011cites this paper
• [Evaluation of bone mineral density, bone turnover markers, the OPG/RANKL system and sTNF-RI in Crohn's disease].

  2011cites this paper
• Bone disease in patients with primary sclerosing cholangitis.

  2011cites this paper
• Gut–Bone Interactions and Implications for the Child With Chronic Gastrointestinal Disease

  2011cites this paper
• Alteraciones del metabolismo óseo en 100 pacientes con enfermedad inflamatoria intestinal

  2011cites this paper
• Bone mineral density in pediatric inflammatory bowel disease

  2010influential citation
• Effect of exclusive enteral nutrition on bone turnover in children with Crohn’s disease

  2010cites this paper
• Clinical relevance of changes in bone metabolism in inflammatory bowel disease.

  2010cites this paper
• TESIS DOCTORAL EFECTO DE ADALIMUMAB SOBRE EL METABOLISMO MINERAL ÓSEO EN LA ENFERMEDAD DE CROHN

  2010cites this paper
• Metabolic Bone Disease in Gastrointestinal Disorders

  2010cites this paper
• Bone Homeostasis in Intestinal Disorders

  2010cites this paper
• New pathophysiological insights and modern treatment of IBD

  2010cites this paper
• How activity of inflammatory bowel disease influences bone loss.

  2010cites this paper
• Use of risedronate to prevent bone loss following a single course of glucocorticoids: findings from a proof-of-concept study in inflammatory bowel disease

  2010cites this paper
• IL-6 May Modulate the Skeletal Response to Glucocorticoids During Exacerbations of Inflammatory Bowel Disease

  2010cites this paper
• 16. Metabolic Bone Disease in Gastrointestinal Disorders

  2010cites this paper
• The frequency of low bone mineral density and its associated risk factors in patients with inflammatory bowel diseases

  2010cites this paper
• Veränderung der Knochengeometrie und Knochendichte bei pädiatrischen Patienten mit chronisch entzündlichen Darmerkrankungen

  2010cites this paper
• ESPEN Guidelines on Parenteral Nutrition: gastroenterology.

  2009cites this paper
• Enteral nutrition as a primary therapy of Crohn's disease: the pediatric perspective.

  2009cites this paper
• Low bone mineral density in children and adolescents with inflammatory bowel disease: A population‐based study from Western Sweden

  2009cites this paper
• Bone mineral metabolism in inflammatory bowel disease

  2009cites this paper
• Osteoporosi nelle malattie gastroenteriche

  2009cites this paper